Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.

Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision label changed from v3.6.2 to v3.6.3, signaling a new revision snapshot of the study record history. It reflects maintenance/versioning rather than updates to the study data or content.SummaryDifference0.1%

- Check19 days agoChange DetectedThe revision label in the history has been updated to v3.6.2, replacing v3.6.0, reflecting a small update to the history record.SummaryDifference0.1%

- Check34 days agoChange DetectedThe history shows the trial is no longer enrolling and introduces a new revision label v3.6.0, while the old revision label v3.5.5 is removed.SummaryDifference0.3%

- Check41 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the previous v3.5.4 entry was removed. This updates the page's version trail.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the page's history and the previous entry v3.5.3 was removed.SummaryDifference0.1%

- Check69 days agoChange DetectedUpdated the study record to Completed with Results Posted, including Adverse Events, Outcome Measures (Results), Participant Flow, and Recruitment/Study Status. The previous Active, not recruiting and Results Submitted entries were removed, reflecting the trial's completion and public availability of final data.SummaryDifference0.8%

Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.